Value based procurement for medical technology

AI Summary

This guidance outlines the implementation of Value-Based Procurement (VBP) by the NHS for the acquisition of medical technology. Moving beyond traditional models that prioritize initial purchase price, this framework provides a standardized methodology for evaluating the broader systemic impact of technology investments. While the document does not reference a specific company or list regulatory violations, it establishes a critical regulatory framework for NHS buyers to assess productivity and hospital efficiency. The core requirements involve using a specific set of scoring criteria and questions to measure impact on patient outcomes, staff safety, and environmental sustainability. Additionally, the guidance emphasizes the importance of supply chain resilience in procurement decisions. Required actions for NHS procurement teams include the adoption of these standardized metrics to ensure that technology choices contribute to long-term healthcare improvements and operational safety. By quantifying non-monetary benefits, the NHS aims to optimize resource allocation and improve the overall delivery of care across both hospital and community settings.